Neoleukin Therapeutics down after announcing reverse stock split

Neurogene

22/09/2023 13:53

** Neoleukin Therapeutics'  NLTX.O  shares fall 1.3% to 69
cents premarket
    ** Co says it will initiate a reverse stock split of its
common stock at a ratio of 1-for-5 
    ** Stock split will be effective from Sept. 25 
    ** Says stock split is part of NLTX's plan to regain
compliance with Nasdaq's  minimum bid price requirement 
    ** Up to last close, shares up 37.3% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))